Earnings Per Share, Basic in USD/shares of Propanc Biopharma, Inc. from Q1 2021 to Q3 2025

Taxonomy & unit
us-gaap: USD/shares
Description
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.
Summary
Propanc Biopharma, Inc. quarterly/annual Earnings Per Share, Basic history and change rate from Q1 2021 to Q3 2025.
  • Propanc Biopharma, Inc. Earnings Per Share, Basic for the quarter ending 30 Sep 2025 was -0.39 USD/shares, a 98.9% increase year-over-year.
  • Propanc Biopharma, Inc. Earnings Per Share, Basic for the twelve months ending 30 Sep 2025 was 20 USD/shares.
  • Propanc Biopharma, Inc. annual Earnings Per Share, Basic for 2025 was -14.9 USD/shares.
  • Propanc Biopharma, Inc. annual Earnings Per Share, Basic for 2024 was -1.42K USD/shares.
  • Propanc Biopharma, Inc. annual Earnings Per Share, Basic for 2023 was -1.8 USD/shares, a 96.3% increase from 2022.
Earnings Per Share, Basic, Trailing 12 Months (USD/shares)
Earnings Per Share, Basic, Quarterly (USD/shares)
Earnings Per Share, Basic, YoY Quarterly Change (%)
Earnings Per Share, Basic, Annual (USD/shares)
Earnings Per Share, Basic, YoY Annual Change (%)

Propanc Biopharma, Inc. Quarterly Earnings Per Share, Basic (USD/shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $20.00 $0 +$35.60 +98.9% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025
Q2 2025 -$14 $65.90 01 Apr 2025 30 Jun 2025 10-K 29 Sep 2025
Q1 2025 -$13 +$533 +97.7% 01 Jan 2025 31 Mar 2025 10-Q 15 May 2025
Q4 2024 -$32 -$31 -1967% 01 Oct 2024 31 Dec 2024 10-Q 14 Feb 2025
Q3 2024 -$36 -$36 -89825% 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025
Q1 2024 -$546 -$546 -$545 -129850% 01 Jan 2024 31 Mar 2024 10-Q 15 May 2025
Q4 2023 $0 -$2 -$1 -194% 01 Oct 2023 31 Dec 2023 10-Q 14 Feb 2025
Q3 2023 $0 $0 +$2.09 +98.1% 01 Jul 2023 30 Sep 2023 10-Q 14 Nov 2024
Q2 2023 -$1 $1.28 +$50.50 01 Apr 2023 30 Jun 2023 10-K 30 Sep 2024
Q1 2023 -$52 $0 $0 -4100% 01 Jan 2023 31 Mar 2023 10-Q 15 May 2024
Q4 2022 -$51 -$1 -$1 -2550% 01 Oct 2022 31 Dec 2022 10-Q 20 Feb 2024
Q3 2022 -$51 -$2 -$2 -10550% 01 Jul 2022 30 Sep 2022 10-Q 14 Nov 2023
Q2 2022 -$49 -$49 01 Apr 2022 30 Jun 2022 10-K 28 Sep 2023
Q1 2022 $0 +$0.11 +91.7% 01 Jan 2022 31 Mar 2022 10-Q 15 May 2023
Q4 2021 $0 01 Oct 2021 31 Dec 2021 10-Q 10 Feb 2023
Q3 2021 $0 01 Jul 2021 30 Sep 2021 10-Q 14 Nov 2022
Q1 2021 $0 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022

Propanc Biopharma, Inc. Annual Earnings Per Share, Basic (USD/shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$15 +$1.41K 01 Jul 2024 30 Jun 2025 10-K 29 Sep 2025
2024 -$1.42K* -$1.42K 01 Jul 2023 30 Jun 2024 10-K 29 Sep 2025
2023 -$2 +$47.40 +96.3% 01 Jul 2022 30 Jun 2023 10-K 30 Sep 2024
2022 -$49 -$48 -6054% 01 Jul 2021 30 Jun 2022 10-K 28 Sep 2023
2021 -$1 01 Jul 2020 30 Jun 2021 10-K 28 Sep 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.